ProPhase Labs, Inc. (PRPH)
0.4475
-0.01
(-1.28%)
USD |
NASDAQ |
Dec 31, 16:00
0.4403
-0.01
(-1.61%)
After-Hours: 20:00
ProPhase Labs Free Cash Flow: -11.15M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| FONAR Corp. | 7.016M |
| XWELL, Inc. | -15.12M |
| Veracyte, Inc. | 98.21M |
| Insight Molecular Diagnostics, Inc. | -23.91M |
| Exagen, Inc. | -10.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.486M |
| Cash from Financing (Quarterly) | 3.722M |
| Free Cash Flow Per Share (Quarterly) | -0.8392 |
| Free Cash Flow to Equity (Quarterly) | -3.304M |
| Free Cash Flow to Firm (Quarterly) | -1.972M |
| Free Cash Flow Yield | -725.5% |